Search research articles
Contact Us
Filters
Showing results (171-180 of 294) with videos related to
Page
of 30
Sort By:
Transplantation Proceedings
|
April 1, 1996
Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression
M D'Silva, A DeRoover, Y Nishimura, et al.
Lancet (London, England)
|
June 25, 1988
Cyclosporin-associated cerebral lesions in liver transplantation
A P Boon, D H Adams, M P Carey, et al.
The Ulster Medical Journal
|
October 1, 1985
An automated blood culture system: the detection of anaerobic bacteria using a Malthus Microbiological Growth Analyser
J P McMaster, J G Barr, R R Campbell, et al.
Transplantation Proceedings
|
November 20, 1997
Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation
M Xu, E A Antoniou, S C Afford, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1996
Two-year data from the European multicentre tacrolimus (FK506) liver study
R Williams, P Neuhaus, H Bismuth, et al.
Transplantation Proceedings
|
October 1, 1990
Human hepatic preservation using Marshall's solution and University of Wisconsin solution in a controlled, prospective trial
I L Badger, I D Michell, L J Buist, et al.
Transplantation Proceedings
|
August 15, 2002
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation
J W C Chen, M Pehlivan, B K Gunson, et al.
The British Journal of Surgery
|
August 10, 2000
Changing referral pattern of biliary injuries sustained during laparoscopic cholecystectomy
S R Shah, D F Mirza, R Afonso, et al.
Lancet (London, England)
|
October 1, 1994
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection
A J Krentz, J Dmitrewski, D Mayer, et al.
Gut
|
March 1, 1995
Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis
D Mutimer, J Shaw, J Neuberger, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 294) with videos related to
Sort By:
Page
of 30
Transplantation Proceedings
|
April 1, 1996
Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression
M D'Silva, A DeRoover, Y Nishimura, et al.
Lancet (London, England)
|
June 25, 1988
Cyclosporin-associated cerebral lesions in liver transplantation
A P Boon, D H Adams, M P Carey, et al.
The Ulster Medical Journal
|
October 1, 1985
An automated blood culture system: the detection of anaerobic bacteria using a Malthus Microbiological Growth Analyser
J P McMaster, J G Barr, R R Campbell, et al.
Transplantation Proceedings
|
November 20, 1997
Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation
M Xu, E A Antoniou, S C Afford, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1996
Two-year data from the European multicentre tacrolimus (FK506) liver study
R Williams, P Neuhaus, H Bismuth, et al.
Transplantation Proceedings
|
October 1, 1990
Human hepatic preservation using Marshall's solution and University of Wisconsin solution in a controlled, prospective trial
I L Badger, I D Michell, L J Buist, et al.
Transplantation Proceedings
|
August 15, 2002
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation
J W C Chen, M Pehlivan, B K Gunson, et al.
The British Journal of Surgery
|
August 10, 2000
Changing referral pattern of biliary injuries sustained during laparoscopic cholecystectomy
S R Shah, D F Mirza, R Afonso, et al.
Lancet (London, England)
|
October 1, 1994
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection
A J Krentz, J Dmitrewski, D Mayer, et al.
Gut
|
March 1, 1995
Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis
D Mutimer, J Shaw, J Neuberger, et al.
Page
of 30